 |
 |
 |
 |
|
| State |
Study Site |
Indication |
Title |
Description |
Details |
TX
|
Arlington (South ) Bedford (Edwards CCRAD ) Dallas (Medical City, Methodist ) Fort Worth (12th Ave., 8th Rad Only, Klabzuba Rad ) Longview, Odessa, Sherman, Sugar Land
|
Brain Cancer |
A Randomized, Phase III, Double-Blind, Placebo-Controlled Trial Of Memantine For Prevention Of Cognitive Dysfunction In Patients Receiving Whole-Brain Radiotherapy |
|
View |
TX
|
Bedford (Edwards CCRAD, Harris HEB ) Dallas (Methodist ) Fort Worth (12th Ave., 8th Rad Only, Klabzuba Rad ) Sherman, Sugar Land
|
Brain Cancer |
Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma |
|
View |
TX
|
Dallas (Medical City, Presbyterian, Sammons CC ) El Paso (East, West ) Houston (Frostwood ) Plano
|
Breast Cancer |
A Multicenter Phase III Randomized Trial of Adjuvant Therapy for Patients with HER2-Positive Node-Positive or High Risk Node-Negative Breast Cancer Comparing Chemotherapy Plus Trastuzumab with Chemotherapy Plus Trastuzumab Plus Bevacizumab |
|
View |
TX
|
Austin (901 W. 38th, Balcones, Cancer Center, Research, Round Rock, Seton Parkway, Renfert ) Bedford (Harris HEB ) Dallas (Medical City, Presbyterian, Sammons CC ) Houston (Frostwood ) Plano, San Marcos, Tyler
|
Breast Cancer |
A Phase 2 Multicenter Study Evaluating the Efficacy and Safety of IPI-504 in Combination with Trastuzumab in Patients with Pretreated, Locally Advanced or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2) - Positive Breast Cancer |
|
View |
TX
|
Austin (901 W. 38th, Balcones, Cancer Center, Research, Round Rock, Seton Parkway, Renfert ) Dallas (Sammons CC ) San Marcos, Tyler
|
Breast Cancer |
A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients with Metastatic Breast Cancer |
|
View |
TX
|
Bedford (Harris HEB ) Dallas (Medical City, Presbyterian, Sammons CC ) Houston (Frostwood ) Plano, Tyler
|
Breast Cancer |
A Phase 2, multicenter, randomized, open-label study comparing eribulin mesylate and ixabepilone in causing or exacerbating neuropathy in patients with advanced breast cancer |
|
View |
TX
|
Longview, McAllen, Midland, Weslaco
|
Breast Cancer |
A Phase 2, Randomized, Double-Blind, Multicenter Study of Exemestane With and Without SNDX-275 in Postmenopausal Women with Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer, Progressing on Treatment with a Non-Steroidal Aromatase I |
|
View |
TX
|
Austin (901 W. 38th, Balcones, Cancer Center, Research, Round Rock, Seton Parkway, Renfert ) Bedford (Harris HEB ) Dallas (Medical City, Presbyterian, Sammons CC ) Fort Worth (12th Ave., Southwest ) Houston (Frostwood ) Plano, San Marcos, Tyler
|
Breast Cancer |
A Phase 3, Multi-center, Open-Label, Randomized Trial of Gemcitabine/Carboplatin, with or without BSI-201, in patients with ER, PR, and HER2-negative metastatic breast cancer |
|
View |
TX
|
Austin (901 W. 38th, Balcones, Cancer Center, Research, Round Rock, Seton Parkway, Renfert ) Bedford (Harris HEB ) Dallas (Medical City, Presbyterian, Sammons CC ) El Paso (East, West ) Houston (Frostwood ) Plano, San Marcos, Tyler
|
Breast Cancer |
A Phase 3, Randomized, Open-Label Study of Neratinib Versus Lapatinib Plus Capecitabine for the Treatment of ErbB-2–Positive Locally Advanced or Metastatic Breast Cancer |
|
View |
TX
|
Abilene (South ) Amarillo, Arlington (South ) Austin (901 W. 38th, Balcones, Cancer Center, Research, Round Rock, Seton Parkway, Renfert ) Beaumont, Bedford (Harris HEB ) Cedar Park, Dallas (Medical City, Methodist, Presbyterian, Sammons CC ) Denton, El Paso (East, West ) Fort Worth (12th Ave., Southwest ) Garland (Walter Reed ) Houston (Frostwood ) Lewisville, Longview, McAllen, Mesquite, Midland, Odessa, Paris, PlanoWest ) San Marcos, Sherman, Sugar Land, Tyler, Waco, Webster- Clear Lake ) Weslaco, Wichita Falls
|
Breast Cancer |
A Phase III Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women with Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer |
|
View |
TX
|
Arlington (South ) Bedford (Edwards CCRAD, Harris HEB ) Dallas (Methodist ) Fort Worth (12th Ave., 8th Rad Only, Klabzuba Rad ) Longview, Odessa, Sherman, Sugar Land
|
Breast Cancer |
A Phase III Clinical Trial Comparing Trastuzumab Given Concurently with Radiation and Radiation Alone for Women with Her2-Postive Ductal Carcinoma In Situ (DCIS) Resected by Lumpectomy |
|
View |
TX
|
Austin (901 W. 38th, Balcones, Cancer Center, Research, Round Rock, Seton Parkway, Renfert ) Bedford (Harris HEB ) Dallas (Medical City, Presbyterian, Sammons CC ) Denton, El Paso (East, West ) Fort Worth (12th Ave., Southwest ) Garland (Walter Reed ) Houston (Frostwood ) Paris, PlanoWest ) San Marcos, Sugar Land, Tyler
|
Breast Cancer |
A Randomized Double Blind Placebo-Controlled Trial of Neratinib (HKI-272) Following Trastuzumab in Women With Early-Stage HER-2/neu Overexpressed/Amplified Breast Cancer
|
|
View |
TX
|
Bedford (Edwards CCRAD ) Dallas (Medical City, Methodist ) Fort Worth (12th Ave., 8th Rad Only, Klabzuba Rad ) Sherman, Sugar Land
|
Breast Cancer |
A Randomized Phase III Study of Conventional Whole Breast
Irradiation (WBI) Versus Partial Breast Irradiation (PBI)
for Women with Stage 0, I, or II Breast Cancer (RTOG) |
|
View |
TX
|
Austin (901 W. 38th, Balcones, Cancer Center, Research, Round Rock, Seton Parkway, Renfert ) Cedar Park, San Marcos, Tyler
|
Breast Cancer |
A randomized phase III, double-blind, placebo-controlled multicenter trial of everolimus in combination with trastuzumab and paclitaxel, as first line therapy in women with HER2-positive locally advanced or metastatic breast cancer |
|
View |
TX
|
Abilene (South ) Beaumont, Bedford (Harris HEB ) Dallas (Methodist ) Fort Worth (12th Ave., Southwest ) Longview, McAllen, Mesquite, Midland, Paris, Sherman, Sugar Land, Tyler, Waco, Weslaco, Wichita Falls
|
Breast Cancer |
A Randomized, Multi-Centre, Open-Label, Phase III Study of Adjuvant Lapatinib, Trastuzumab, Their Sequence and Their Combination in Patients with HER2/ErbB2 Positive Primary Breast Cancer |
|
View |
TX
|
Austin (901 W. 38th, Balcones, Cancer Center, Research, Round Rock, Seton Parkway, Renfert ) Bedford (Harris HEB ) Dallas (Medical City, Presbyterian, Sammons CC ) Denton, El Paso (East, West ) Houston (Frostwood ) Plano, San Marcos, Tyler, Waco, Webster- Clear Lake )
|
Breast Cancer |
Phase II Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women who have Hormone Receptor-positive Advanced Breast Cancer Previously Treated with an Aromatase Inhibitor |
|
View |
TX
|
Austin (901 W. 38th, Balcones, Cancer Center, Research, Round Rock, Seton Parkway, Renfert ) Beaumont, Bedford (Harris HEB ) Dallas (Presbyterian, Sammons CC ) El Paso (East, West ) Houston (Frostwood ) San Marcos, Sugar Land, Tyler
|
Breast Cancer |
Phase II Randomized Trial of Neoadjuvant Trastuzumab and/or Lapatinib plus Chemotherapy (Sequential FEC75 and Paclitaxel) in Women with ErbB2- (HER2/neu-) Overexpressing Invasive Breast Cancer |
|
View |
TX
|
Bedford (Harris HEB ) Dallas (Medical City, Presbyterian, Sammons CC ) Houston (Frostwood ) Plano, Tyler
|
Breast Cancer |
Phase II, multicenter, open-label, clinical trial of Trabectedin (Yondelis®) in Metastatic Breast Cancer Patients with triple negative profile (ER-, PR-, HER2-), HER2 overexpressing tumors and BRCA1 or BRCA2 mutation carriers.
|
|
View |
TX
|
Austin (901 W. 38th, Balcones, Cancer Center, Research, Round Rock, Seton Parkway, Renfert ) Bedford (Harris HEB ) Dallas (Medical City, Presbyterian, Sammons CC ) El Paso (East, West ) Fort Worth (12th Ave., Southwest ) Garland (Walter Reed ) Houston (Frostwood ) PlanoWest ) San Marcos, Tyler, Waco
|
Breast Cancer |
Randomized Phase II Trial of Letrozole with or without Dasatinib as First and Second-Line Treatment for Hormone Receptor-Positive, HER2-Negative Post-Menopausal Breast Cancer that is Unresectable, Locally Recurrent or Metastatic |
|
View |
TX
|
Amarillo, Austin (901 W. 38th, Balcones, Cancer Center, Research, Round Rock, Seton Parkway, Renfert ) Dallas (Methodist, Presbyterian ) Odessa, San Marcos, Tyler
|
Colon Cancer |
A Multi-center, Open-label, Randomized, Phase 2 Clinical Trial Evaluating Safety and Efficacy of FOLFIRI with Either Panitumumab or Bevacizumab as Second-line Treatment in Subjects with Metastatic Colorectal Cancer with Wild-Type KRAS tumors |
|
View |
TX
|
Amarillo, Austin (901 W. 38th, Balcones, Cancer Center, Research, Round Rock, Seton Parkway, Renfert ) Cedar Park, Dallas (Presbyterian ) San Marcos, Tyler
|
Colon Cancer |
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of FOLFIRI in Combination With AMG 479 or AMG 655 Versus FOLFIRI for the Second-Line Treatment of KRAS-Mutant Colorectal Carcinoma |
|
View |
TX
|
Bedford (Edwards CCRAD ) Dallas (Medical City, Methodist ) Fort Worth (12th Ave., 8th Rad Only, Klabzuba Rad ) Sherman, Sugar Land
|
Esophageal Cancer |
A Phase III Trial Evaluating The Addition Of Cetuximab To Paclitaxel, Cisplatin, And Radiation For Patients With Esophageal Cancer Who Are Treated Without Surgery
|
|
View |
TX
|
Austin (Balcones, Cancer Center ) Dallas (Presbyterian, Sammons CC ) El Paso (East, West ) Fort Worth (12th Ave. ) Tyler, Waco
|
Fallopian Tube Cancer |
A Phase III, Multicenter, Randomized, Blinded, Placebo-Controlled Trial of Carboplatin and Gemcitabine Plus Bevacizumab in Patients with Platinum-Sensitive Recurrent Ovary, Primary Peritoneal, or Fallopian Tube Carcinoma |
|
View |
TX
|
Austin (901 W. 38th, Balcones, Cancer Center ) Bedford (Harris HEB ) Dallas (Presbyterian ) Longview, Plano, Waco
|
Fallopian Tube Cancer |
A Randomized Phase II Trial Comparing Ec145 And Pegylated Liposomal Doxorubicin (Pld/Doxil®/Caelyx®) In Combination Versus Pld Alone In Subjects With Platinum-Resistant Ovarian Cancer (PRECEDENT Trial) |
|
View |
TX
|
Amarillo, Arlington (South ) Austin (901 W. 38th, Balcones, Cancer Center, Research, Round Rock, Seton Parkway, Renfert ) Beaumont, Bedford (Harris HEB ) Cedar Park, Dallas (Medical City, Methodist, Presbyterian, Sammons CC ) Denton, El Paso (East, West ) Fort Worth (12th Ave., Southwest ) Garland (Walter Reed ) Lewisville, Longview, Mesquite, Midland, Odessa, Paris, PlanoWest ) San Marcos, Tyler, Waco
|
Gastric Cancer |
Phase II trial of docetaxel plus oxaliplatin (DOCOX) with or without cetuximab in patients with metastatic gastric and/or gastroesophageal junction adenocarcinoma |
|
View |
TX
|
Tyler
|
GI Stromal Tumor (GIST) |
A randomized, multi-center phase III study to evaluate the efficacy and safety of nilotinib versus imatinib in adult patients with unresectable or metastatic gastrointestinal stromal tumors (GIST). |
|
View |
TX
|
Amarillo, Austin (901 W. 38th, Balcones, Cancer Center, Research, Round Rock, Seton Parkway, Renfert ) Bedford (Harris HEB ) Cedar Park, Dallas (Sammons CC ) Tyler, Webster- Clear Lake )
|
Kidney Cancer |
Axitinib (AG-013736) as Second Line Therapy for Metastatic Renal Cell Cancer: AXIS Trial |
|
View |
TX
|
Austin (901 W. 38th, Balcones, Cancer Center, Research, Round Rock, Seton Parkway, Renfert ) Bedford (Harris HEB ) Dallas (Sammons CC ) Fort Worth (12th Ave., Southwest ) San Marcos, Tyler, Webster- Clear Lake ) Wichita Falls
|
Kidney Cancer |
Study VEG108844, a Study of Pazopanib versus Sunitinib in the Treatment of Subjects with Locally Advanced and/or Metastatic Renal Cell Carcinoma |
|
View |
TX
|
Dallas (Medical City ) Odessa, Tyler
|
Leukemia |
A phase III multi-center, open-label, randomized study of imatinib versus nilotinib in adult patients with newly diagnosed Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia in chronic phase (CML-CP)
EXTENSION ONLY |
|
View |
TX
|
Abilene (South ) Arlington (South ) Austin (901 W. 38th, Balcones, Cancer Center, Research, Round Rock, Seton Parkway, Renfert ) Dallas (Medical City, Presbyterian ) Fort Worth (12th Ave., Southwest ) Midland, Odessa, San Marcos, Tyler, Waco, Webster- Clear Lake )
|
Leukemia |
A phase III, open label, randomized, multicenter trial of Ofatumumab added to Chlorambucil vs. Chlorambucil Monotherapy in previously untreated patients with Chronic Lymphocytic Leukemia |
|
View |
TX
|
Amarillo, Austin (901 W. 38th, Balcones, Cancer Center, Research, Round Rock, Seton Parkway, Renfert ) Beaumont, Bedford (Edwards CCRAD, Harris HEB ) Cedar Park, Dallas (Methodist ) El Paso (East, West ) Fort Worth (12th Ave., Southwest ) Garland (Walter Reed ) Longview, McAllen, Odessa, Paris, Plano (West ) San Marcos, Sugar Land, Webster- Clear Lake ) Weslaco, Wichita Falls
|
Liver Cancer |
Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with SorafeNib (GIDEON) |
|
View |
TX
|
Tyler
|
Lung Cancer |
Open-label phase 1b study of erlotinib plus bevacizumab and IMO-2055 in patients with non-small cell lung cancer who have progressed following initial chemotherapy for advanced or metastatic disease |
|
View |
TX
|
Amarillo, Beaumont, Dallas (Medical City, Sammons CC ) Fort Worth (12th Ave., Southwest ) Garland (Walter Reed ) Lewisville, Paris, PlanoWest ) Tyler, Waco
|
Lung Cancer |
A Multi-center Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Single-agent Tarceva (erlotinib) Following Complete Tumor Resection with or without Adjuvant Chemotherapy in Patients with Stage IB-IIIA Non-small Cell Lung Carcinoma who have E |
|
View |
TX
|
Bedford (Harris HEB ) Waco
|
Lung Cancer |
A Phase 3, Multicenter, Randomized, Placebo‑Controlled, Double‑Blind Trial of AMG 706 in Combination With Paclitaxel and Carboplatin for Advanced Non‑small Cell Lung Cancer |
|
View |
TX
|
Abilene (South ) Arlington (South ) Austin (901 W. 38th, Balcones, Cancer Center, Research, Round Rock, Seton Parkway, Renfert ) Beaumont, Bedford (Harris HEB ) Cedar Park, Dallas (Medical City, Methodist, Presbyterian, Sammons CC ) Denton, Garland (Walter Reed ) Longview, Midland, Odessa, Paris, PlanoWest ) San Marcos, Sherman, Tyler, Waco
|
Lung Cancer |
A Phase III, Randomized, Double-Blind, Placebo-Controlled Multi-Center Study of ASA404 in Combination with Docetaxel in Second-Line Treatment of Patients with Locally Advanced or Metastatic (Stage IIIb/IV) Non-Small Cell Lung Cancer (NSCLC) |
|
View |
TX
|
Bedford (Edwards CCRAD ) Dallas (Medical City, Methodist ) Fort Worth (12th Ave., 8th Rad Only, Klabzuba Rad ) Sherman, Sugar Land
|
Lung Cancer |
A RANDOMIZED PHASE III COMPARISON OF STANDARD- DOSE (60 Gy) VERSUS HIGHDOSE (74 Gy) CONFORMAL RADIOTHERAPY WITH CONCURRENT AND CONSOLIDATION CARBOPLATIN/PACLITAXEL +/- CETUXIMAB (IND# 103444)IN PATIENTS WITH STAGE IIIA/IIIB NON-SMALL CELL LUNG CANCER (RTO |
|
View |
TX
|
Abilene (South ) Amarillo, Austin (901 W. 38th, Balcones, Cancer Center, Research, Round Rock, Seton Parkway, Renfert ) Beaumont, Bedford (Harris HEB ) Dallas (Medical City, Methodist, Presbyterian ) El Paso (East, West ) Fort Worth (12th Ave., Southwest ) Garland (Walter Reed ) Longview, McAllen, Mesquite, Midland, Paris, Plano (West ) San Marcos, Sherman, Sugar Land, Tyler, Waco, Webster- Clear Lake ) Weslaco, Wichita Falls
|
Lung Cancer |
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Long-term Safety and Efficacy of Darbepoetin Alfa Administered at 500 µg Once-Every-3-Weeks in Anemic Subjects With Advanced Stage Non-small Cell Lung Cancer Receiving Multi-cycle Chemot |
|
View |
TX
|
Amarillo, Dallas (Medical City, Sammons CC ) Odessa, Plano, Wichita Falls
|
Lung Cancer |
A Randomized, Open-label, Multinational Phase 3 Trial Comparing Amrubicin Versus Topotecan in Patients With Extensive or Limited and Sensitive or Refractory Small Cell Lung Cancer After Failure of First-Line Chemotherapy |
|
View |
TX
|
Bedford (Edwards CCRAD, Harris HEB ) Dallas (Medical City ) Fort Worth (12th Ave., 8th Rad Only, Klabzuba Rad ) Sherman, Sugar Land
|
Lung Cancer |
A randomized, phase III, open-label study of oral topotecan plus
whole-brain radiation therapy (WBRT) compared with WBRT
alone in patients with brain metastases from Non-Small Cell
Lung Cancer |
|
View |
TX
|
Dallas (Medical City ) Fort Worth (12th Ave., Southwest ) Midland, Plano, Tyler
|
Lung Cancer |
FORTIS-M: A Phase 3, randomized, double-blind, placebo-controlled study of oral talactoferrin in addition to best supportive care in patients with non-small cell lung cancer who have failed two or more prior treatment regimens |
|
View |
TX
|
Abilene (South ) Arlington (South ) Austin (901 W. 38th, Balcones, Cancer Center, Research, Round Rock, Seton Parkway, Renfert ) Beaumont, Bedford (Harris HEB ) Cedar Park, Dallas (Medical City, Methodist, Presbyterian ) El Paso (East, West ) Fort Worth (12th Ave., Southwest ) Garland (Walter Reed ) Lewisville, McAllen, Mesquite, Midland, Paris, PlanoWest ) San Marcos, Sherman, Sugar Land, Tyler, Waco, Webster- Clear Lake ) Weslaco
|
Lung Cancer |
Phase II trial of Sunitinib Malate in Previously Untreated NSCLC Patients Over the Age of 70 |
|
View |
TX
|
Mesquite, Sugar Land
|
Lung Cancer |
Randomized Phase III Study of Docetaxel or Pemetrexed with or without Cetuximab in Patients with Recurrent or Progressive Non-Small Cell Lung Cancer after Platinum-Based Therapy (IMCL CP02-0452) |
|
View |
TX
|
Abilene (South ) Arlington (South ) Austin (901 W. 38th, Balcones, Cancer Center, Research, Round Rock, Seton Parkway, Renfert ) Beaumont, Bedford (Harris HEB ) Dallas (Medical City, Methodist, Presbyterian, Sammons CC ) Denton, Fort Worth (12th Ave., Southwest ) Garland (Walter Reed ) Lewisville, Longview, Mesquite, Midland, Paris, PlanoWest ) San Marcos, Sherman, Sugar Land, Tyler, Waco, Webster- Clear Lake )
|
Lung Cancer |
Randomized, Open-Label, Phase 3 Study of Pemetrexed plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab versus Paclitaxel plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients with Stage IIIB or I |
|
View |
TX
|
Abilene (South ) Dallas (Medical City ) Tyler
|
Lymphomas |
A Phase III, Randomized, Double-Blind Study of Galiximab in Combination with Rituximab Compared with Rituximab in Combination with Placebo for the Treatment of Subjects with Relapsed or Refractory, Follicular Non-Hodgkin's Lymphoma |
|
View |
TX
|
Arlington (South ) Fort Worth (12th Ave., Southwest ) Tyler
|
Lymphomas |
An Open-Label, Randomized, Parallel-Group Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With Rituximab, Cyclophosphamide, Vincristine, and Prednisone (R-CVP) or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHO |
|
View |
TX
|
Austin (901 W. 38th, Balcones, Cancer Center, Research, Round Rock, Seton Parkway, Renfert ) Dallas (Medical City ) McAllen, Plano, San Marcos, Tyler, Weslaco, Wichita Falls
|
Lymphomas |
PRELUDE: A Phase 3 Clinical Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin |
|
View |
TX
|
Abilene (South ) Arlington (South ) Austin (901 W. 38th, Balcones, Cancer Center, Research, Round Rock, Seton Parkway, Renfert ) Beaumont, Bedford (Harris HEB ) Dallas (Medical City, Presbyterian ) San Marcos
|
Myelodysplastic Syndrome |
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Epoetin Alfa Initiated at 40,000 IU Every Week or 80,000 IU Every Week Versus Placebo in Subjects With IPSS Low- or Intermediate-1 Risk Myelodysplastic Syndromes at Risk For Tran |
|
View |
TX
|
Abilene (South ) Arlington (South ) Austin (901 W. 38th, Balcones, Cancer Center, Research, Round Rock, Seton Parkway, Renfert ) Beaumont, Bedford (Harris HEB ) Dallas (Medical City, Presbyterian, Sammons CC ) Garland (Walter Reed ) Longview, Mesquite, Midland, Paris, PlanoWest ) San Marcos, Sherman, Tyler, Waco
|
Myelomas |
Randomized Phase 3b Study of Three Treatment Regimens in Subjects with Previously Untreated Multiple Myeloma Who Are Not Considered Candidates for High-Dose Chemotherapy and Autologous Stem Cell Transplantation: VELCADE® (Bortezomib), Thalidomide, and Dex |
|
View |
TX
|
Austin (Balcones, Cancer Center ) Dallas (Presbyterian, Sammons CC ) El Paso (East, West ) Fort Worth (12th Ave. ) Tyler, Waco
|
Ovarian Cancer |
A Phase III, Multicenter, Randomized, Blinded, Placebo-Controlled Trial of Carboplatin and Gemcitabine Plus Bevacizumab in Patients with Platinum-Sensitive Recurrent Ovary, Primary Peritoneal, or Fallopian Tube Carcinoma |
|
View |
TX
|
Austin (901 W. 38th, Balcones, Cancer Center ) Bedford (Harris HEB ) Dallas (Presbyterian ) Longview, Plano, Waco
|
Ovarian Cancer |
A Randomized Phase II Trial Comparing Ec145 And Pegylated Liposomal Doxorubicin (Pld/Doxil®/Caelyx®) In Combination Versus Pld Alone In Subjects With Platinum-Resistant Ovarian Cancer (PRECEDENT Trial) |
|
View |
TX
|
Dallas (Methodist, Presbyterian ) Tyler
|
Pancreatic Cancer |
A Phase 2 Double-Blind, Placebo Controlled, Multi-center Adjuvant Trial of the Efficacy, Immunogenicity, and Safety of GI-4000; an Inactivated Recombinant Saccharomyces cerevisiae Expressing Mutant Ras Protein Combined with a Gemcitabine Regimen Versus a |
|
View |
TX
|
Austin (Balcones, Cancer Center ) Dallas (Presbyterian, Sammons CC ) El Paso (East, West ) Fort Worth (12th Ave. ) Tyler, Waco
|
Peritoneal Cancer |
A Phase III, Multicenter, Randomized, Blinded, Placebo-Controlled Trial of Carboplatin and Gemcitabine Plus Bevacizumab in Patients with Platinum-Sensitive Recurrent Ovary, Primary Peritoneal, or Fallopian Tube Carcinoma |
|
View |
TX
|
Austin (901 W. 38th, Balcones, Cancer Center ) Bedford (Harris HEB ) Dallas (Presbyterian ) Longview, Plano, Waco
|
Peritoneal Cancer |
A Randomized Phase II Trial Comparing Ec145 And Pegylated Liposomal Doxorubicin (Pld/Doxil®/Caelyx®) In Combination Versus Pld Alone In Subjects With Platinum-Resistant Ovarian Cancer (PRECEDENT Trial) |
|
View |
TX
|
Arlington (South ) Dallas (Sammons CC ) Webster- Clear Lake )
|
Prostate Cancer |
A Multicenter, Randomized, Double-Blind, Phase 3 Study Of Sunitinib Plus Prednisone Versus Prednisone In Patients With Progressive Metastatic Hormone-Refractory Prostate Cancer After Failure Of A Docetaxel-Based Chemotherapy Regimen |
|
View |
TX
|
Bedford (Edwards CCRAD ) Dallas (Medical City, Methodist ) Fort Worth (12th Ave., 8th Rad Only, Klabzuba Rad ) Sherman, Sugar Land
|
Prostate Cancer |
A PHASE III RANDOMIZED STUDY OF HYPOFRACTIONATED 3D-CRT/IMRT VERSUS CONVENTIONALLY FRACTIONATED 3D-CRT/IMRT IN PATIENTS WITH FAVORABLE-RISK PROSTATE CANCER (RTOG) |
|
View |
TX
|
Bedford (Edwards CCRAD ) Dallas (Medical City, Methodist ) Fort Worth (12th Ave., 8th Rad Only, Klabzuba Rad ) Sherman, Sugar Land
|
Prostate Cancer |
A Phase III Trial Of Short Term Androgen Deprivation With Pelvic Lymph
Node Or Prostate Bed Only Radiotherapy (Spport) In Prostate Cancer
Patients With A Rising Psa After Radical Prostatectomy |
|
View |
TX
|
Amarillo, Austin (901 W. 38th, Balcones, Cancer Center, Research, Round Rock, Seton Parkway, Renfert ) Beaumont, Dallas (Medical City, Methodist, Sammons CC ) Denton, El Paso (East, West ) Fort Worth (12th Ave., Southwest ) Lewisville, Midland, Odessa, Paris, Plano, Sherman, Sugar Land, Tyler, Waco, Webster- Clear Lake ) Wichita Falls
|
Rectal Cancer |
A randomized Phase II trial of pre-operative chemoradiotherapy with or without cetuximab (ERBITUX(R)) in locally-advanced adenocarcinoma of the rectum |
|
View |
TX
|
Bedford (Harris HEB ) Dallas (Sammons CC )
|
Renal Cancer |
A Treatment Protocol for Patients continuing from a prior SU011248 Protocol
|
|
View |
TX
|
Amarillo, Austin (901 W. 38th, Balcones, Cancer Center, Research, Round Rock, Seton Parkway, Renfert ) Bedford (Harris HEB ) Cedar Park, Dallas (Sammons CC ) Tyler, Webster- Clear Lake )
|
Renal Cancer |
Axitinib (AG-013736) as Second Line Therapy for Metastatic Renal Cell Cancer: AXIS Trial |
|
View |
TX
|
Austin (901 W. 38th, Balcones, Cancer Center, Research, Round Rock, Seton Parkway, Renfert ) Bedford (Harris HEB ) Dallas (Sammons CC ) Fort Worth (12th Ave., Southwest ) San Marcos, Tyler, Webster- Clear Lake ) Wichita Falls
|
Renal Cancer |
Study VEG108844, a Study of Pazopanib versus Sunitinib in the Treatment of Subjects with Locally Advanced and/or Metastatic Renal Cell Carcinoma |
|
View |
TX
|
Dallas (Sammons TOPS )
|
Solid Tumors |
A Phase 1, Multicenter, Open-Label, Single-Arm, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-575, a Fully Human Monoclonal Antibody Directed Against Platelet-Derived Growth Factor Receptor-alpha (PDGFR-alpha), |
|
View |
TX
|
Dallas (Sammons TOPS ) Tyler
|
Solid Tumors |
A Phase I Open Label, Multicenter, Dose-Escalation Study to Determine the Maximum Tolerated Dose (MTD), Dose Limiting Toxicity (DLT), Safety and Pharmacokinetics of PG-11047 when Used in Individual Combinations with 1) Gemcitabine or 2) Docetaxel or 3) Be |
|
View |
TX
|
Dallas (Sammons TOPS ) Tyler
|
Solid Tumors |
A randomized Phase 1b/2 study of LY2603618 IV administered 1 day after gemcitabine IV every 28 days versus gemcitabine for patients with pancreatic cancer |
|
View |
TX
|
Abilene (South ) Amarillo, Austin (901 W. 38th, Balcones, Cancer Center, Research, Round Rock, Seton Parkway, Renfert ) Beaumont, Bedford (Harris HEB ) Dallas (Medical City, Methodist, Presbyterian ) El Paso (East, West ) Fort Worth (12th Ave., Southwest ) Garland (Walter Reed ) Longview, McAllen, Mesquite, Midland, Paris, Plano (West ) San Marcos, Sherman, Sugar Land, Tyler, Waco, Webster- Clear Lake ) Weslaco, Wichita Falls
|
Supportive Care |
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Long-term Safety and Efficacy of Darbepoetin Alfa Administered at 500 µg Once-Every-3-Weeks in Anemic Subjects With Advanced Stage Non-small Cell Lung Cancer Receiving Multi-cycle Chemot |
|
View |
TX
|
Abilene (South ) Arlington (South ) Austin (901 W. 38th, Balcones, Cancer Center, Research, Round Rock, Seton Parkway, Renfert ) Beaumont, Bedford (Harris HEB ) Dallas (Medical City, Presbyterian ) San Marcos
|
Supportive Care |
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Epoetin Alfa Initiated at 40,000 IU Every Week or 80,000 IU Every Week Versus Placebo in Subjects With IPSS Low- or Intermediate-1 Risk Myelodysplastic Syndromes at Risk For Tran |
|
View |
|
|
|
 |
|
 |
|
 |